["{\n\"step_by_step_thinking\": \"There is no direct evidence that major brain gangliosides are a target for the treatment of Alzheimer's disease as of Feb 2019. The studies provided suggest alterations in ganglioside composition and concentration in Alzheimer's disease, but do not explicitly indicate their use as a therapeutic target. While some studies propose possible mechanisms, such as accelerated lysosomal degradation of gangliosides or astrogliosis, these findings are observational and do not provide conclusive evidence for the treatment of Alzheimer's disease.\",\n\"answer_choice\": \"B\"\n}"]